Cannabis and Epilepsy

References

• Alger, B. E. (2014). Seizing an opportunity for the endocannabinoid system. Epilepsy Currents, 14(5), 272–276. doi:10.5698/1535-7597-14.5.272
   PubMed Web of Science ®Google Scholar
• Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., … Di Marzo, V. (2001). Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. British Journal of Pharmacology, 134(4), 845. doi:10.1038/sj.bjp.0704327
   PubMed Web of Science ®Google Scholar
• Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012). Endocannabinoid signaling and synaptic function. Neuron, 76(1), 70–81. doi:10.1016/j.neuron.2012.09.020
   PubMed Web of Science ®Google Scholar
• Consroe, P., Martin, P., & Eisenstein, D. (1977). Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits. Research Communications in Chemical Pathology and Pharmacology, 16, 1–13.
   PubMedGoogle Scholar
• Consroe, P. F., Wood, G. C., & Buchsbaum, H. (1975). Anticonvulsant nature of marihuana smoking. JAMA, 234(3), 306–367. doi:10.1001/jama.1975.03260160054015
   PubMed Web of Science ®Google Scholar
• Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., … Mechoulam, R. (1980). Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 21(3), 175–185. doi:10.1159/000137430
   PubMed Web of Science ®Google Scholar
• Davis, J. P., & Ramsey, H. H. (1949). Antiepileptic action of marijuana-active substances. Federation Proceedings, 8, 284–285.
   Google Scholar
• Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., … Mechoulame, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946–1949. doi:10.1126/science.1470919
   PubMed Web of Science ®Google Scholar
• Devinsky, O., Cilio, M. R., Cross, H., Fernandez-Ruiz, J., French, J., Hill, C., … Friedman, D. (2014). Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791–802. doi:10.1111/epi.12631
   PubMed Web of Science ®Google Scholar
• Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., … Cannabidiol In Dravet Syndrome, S. G. (2017). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 376(21), 2011–2020. doi:10.1056/NEJMoa1611618
   PubMed Web of Science ®Google Scholar
• Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., … Zuberi, S. M. (2018). Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. New England Journal of Medicine, 378(20), 1888–1897. doi:10.1056/NEJMoa1714631
   PubMed Web of Science ®Google Scholar
• Doyle, A., & Alick, S. (2018). Choosing Antiepileptic Drugs: As the number of available antiepileptic drugs increases, so does the challenge of choosing the most appropriate drug for a given patient. Practical Neurology.
   Google Scholar
• Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., … Wiebe, S. (2014). ILAE official report: A practical clinical definition of epilepsy. Epilepsia, 55(4), 475–482. doi:10.1111/epi.12550
   PubMed Web of Science ®Google Scholar
• Friedman, D., & Sirven, J. I. (2017). Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s. Epilepsy & Behavior, 70, 298–302. doi:10.1016/j.yebeh.2016.11.033
   PubMed Web of Science ®Google Scholar
• Gaoni, Y., & Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society, 86(8), 1646–1647. doi:10.1021/ja01062a046
   Web of Science ®Google Scholar
• Gaston, T. E., & Friedman, D. (2017). Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy & Behavior, 70, 313–318. doi:10.1016/j.yebeh.2016.11.016
   PubMed Web of Science ®Google Scholar
• Hall, W., & Solowij, N. (1998). Adverse effects of cannabis. The Lancet, 352(9140), 1611–1616. doi:10.1016/S0140-6736(98)05021-1
   PubMed Web of Science ®Google Scholar
• Herkenham, M., Groen, B. G., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991). Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Research, 552(2), 301–310. doi:10.1016/0006-8993(91)90096-E
   PubMed Web of Science ®Google Scholar
• Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1991). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. The Journal of Neuroscience, 11(2), 563–583. doi:10.1523/JNEUROSCI.11-02-00563.1991
   PubMed Web of Science ®Google Scholar
• Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990). Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America, 87, (5), 1932–1936. doi:10.1073/pnas.87.5.1932
   PubMed Web of Science ®Google Scholar
• Jones, N. A., Hill, A. J., Smith, I., Bevan, S. A., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2010). Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics, 332(2), 569–577. doi:10.1124/jpet.109.159145
   PubMed Web of Science ®Google Scholar
• Joy, J. E., Watson, S. J., Benson, J. A. Jr, & Institute of Medicine (US). (1999). Marijuana and medicine: Assessing the science base. Washington, DC: National Academies Press.
   Google Scholar
• Karler, R., & Turkanis, S. A. (1976). The antiepileptic potential of the cannabinoids. In S. Cohen & R. C. Stillman (Eds.), The therapeutic potential of marihuana (p. 383). New York, NY: Plenum Medical Book Company.
   Google Scholar
• Kwan, P., Schachter, S. C., & Brodie, M. J. (2011). Drug-resistant epilepsy. New England Journal of Medicine, 365(10), 919–926. doi:10.1056/NEJMra1004418
   PubMed Web of Science ®Google Scholar
• Lorenz, R. (2004). On the application of cannabis in paediatrics and epileptology. Neuroendocrinology Letters, 25, 40–44.
   PubMed Web of Science ®Google Scholar
• Maa, E., & Figi, P. (2014). The case for medical marijuana in epilepsy. Epilepsia, 55(6), 783–786. doi:10.1111/epi.12610
   PubMed Web of Science ®Google Scholar
• Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, C. A., & Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561–564. doi:10.1038/346561a0
   PubMed Web of Science ®Google Scholar
• Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., … Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology, 50(1), 83–90. doi:10.1016/0006-2952(95)00109-D
   PubMed Web of Science ®Google Scholar
• Mechoulam, R., & Gaoni, Y. (1967). The absolute configuration of Δ-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Letters, 12, 1109–1111. doi:10.1016/S0040-4039(00)90646-4
   PubMed Web of Science ®Google Scholar
• Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365(6441), 61–65. doi:10.1038/365061a0
   PubMed Web of Science ®Google Scholar
• Nair, D. (2016). Management of drug-resistant epilepsy. Continuum, 22(1), 157–172. doi:10.1212/CON.0000000000000297
   PubMedGoogle Scholar
• O’Shaughnessy, W. B. (1843). On the preparations of the Indian hemp, or gunjah: Cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Provincial Medical Journal and Retrospect of the Medical Sciences, 5(123), 363. doi:10.1136/bmj.s1-5.122.343
   Google Scholar
• Pass, W. (2018). Exploring CB1, CB2 in various neurological conditions. Neurologylive.com
   Google Scholar
• Patel, R. R., Barbosa, C., Brustovetsky, T., Brustovetsky, N., & Cummins, T. R. (2016). Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. Brain, 139(8), 2164–2181. doi:10.1093/brain/aww129
   PubMedGoogle Scholar
• Pelliccia, A., Grassi, G., Romano, A., & Crocchiolo, P. (2005). Treatment with CBD in oily solution of drug-resistant paediatric epilepsies. International Association of Cannabinoid Medicines, Leiden, Netherlands.
   Google Scholar
• Petro, D. J. (1997). Seizure disorders. In M. L. Mathre (Ed.), Cannabis in medical practice: A legal, historical and pharmacological overview of the therapeutic use of marijuana (p. 125). Jefferson, NC: McFarland and Co.
   Google Scholar
• Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015). Cannabinoids and epilepsy. Neurotherapeutics, 12(4), 747–768. doi:10.1007/s13311-015-0375-5
   PubMed Web of Science ®Google Scholar
• Ross, H. R., Napier, I., & Connor, M. (2008). Inhibition of recombinant human T-type calcium channels by delta9-tetrahydrocannabinol and cannabidiol. Journal of Biological Chemistry, 283(23), 16124–16134. doi:10.1074/jbc.M707104200
   PubMed Web of Science ®Google Scholar
• Russo, E. B. (2017). Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy & Behavior, 70, 292–297. doi:10.1016/j.yebeh.2016.09.040
   PubMed Web of Science ®Google Scholar
• St Louis, E. K., & Cascino, G. D. (2016). Diagnosis of epilepsy and related episodic disorders. Continuum, 22(1), 15–37. doi:10.1212/CON.0000000000000284
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration. (2018). Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/
   Google Scholar
• Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., … Waku, K. (1995). 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications, 215(1), 89–97. doi:10.1006/bbrc.1995.2437
   PubMed Web of Science ®Google Scholar
• Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., … Wilfong, A. (2018). Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 391(10125), 1085–1096. doi:10.1016/S0140-6736(18)30136-3
   PubMed Web of Science ®Google Scholar
• Trembly, B., & Sheman, M. (1990). Double-blind clinical study of cannabidiol as a secondary anticonvulsant. Marijuana ‘90 International Conference on Cannabis and Cannabinoids, Kolympari, Crete, Greece.
   Google Scholar
• Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., …Sharkey, K. A. (2005). Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 310(5746), 329–332. doi:10.1126/science.1115740
   PubMed Web of Science ®Google Scholar
• Wallace, M. J., Blair, R. E., Falenski, K. W., Martin, B. R., & DeLorenzo, R. J. (2003). The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. The Journal of Pharmacology and Experimental Therapeutics, 307(1), 129–137. doi:10.1124/jpet.103.051920
   PubMed Web of Science ®Google Scholar
• Wallace, M. J., Martin, B. R., & DeLorenzo, R. J. (2002). Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. European Journal of Pharmacology, 452(3), 295–301. doi:10.1016/s0014-2999(02)02331-2
   PubMed Web of Science ®Google Scholar
• Zendulka, O., Dovrtělová, G., Nosková, K., Turjap, M., Šulcová, A., Hanuš, L., & Juřica, J. (2016). Cannabinoids and cytochrome P450 interactions. Current Drug Metabolism, 17(3), 206–226.
   PubMed Web of Science ®Google Scholar